“This could save lives, cure depression, help alcoholism, get people off opioids—why wouldn’t I want to be invested?” That’s Shark Tank host Kevin O’Leary on his investment into “a new startup called MindMed [that] could have the key to providing the upsides of psychedelic drugs for both focus and addiction treatment—while cutting out the downsides of tripping.” FastCo: Silicon Valley’s psychedelic wonder drug is almost here. (So we can solve many of society’s problem but Kevin O’Leary will get a big payout. Tough call…)